Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.22
Delayed Data
As of Feb 23
 +0.05 / +1.58%
Today’s Change
3.00
Today|||52-Week Range
5.10
-2.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$176.6M

Company Description

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert. It is aslo developing NX-1207 for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Contact Information

Nymox Pharmaceutical Corp.
1 Bay & Deveaux Streets
Nassau New Providence --
P:(800) 936-9669
Investor Relations:

Employees

Shareholders

Individual stakeholders5.71%
Other institutional3.62%
Mutual fund holders2.81%

Top Executives

Paul AverbackChairman, President & Chief Executive Officer
Erik DanielsenChief Financial Officer
Randall LanhamSecretary, General Counsel & Director